CD36 and obesity disorder: Moreover, the anti-obesity impact of IX is partially attributed to its ability to hinder fatty acid absorption, achieved by reducing the expression of the fatty acid transporter CD36 in the small intestine induced by A. muciniphila (Fig. 7).